Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Nvidia Slides as Leadership and Regulatory Turmoil Overshadows Strong Results

None

NVIDIA Corporation (NVDA) is down 13.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The sell-off appears tied mainly to growing uncertainty around NVIDIA’s leadership and regulatory scrutiny, which have overshadowed otherwise strong quarterly results. Investor caution also seems to be rising around margin pressure and the company’s assumption of no China data center compute revenue in its forward outlook.

Details:

  • NVIDIA’s board is dealing with the aftermath of Jensen Huang’s departure, with Colette Kress serving as interim chief executive while the company weighs next steps.
  • The California attorney general has subpoenaed NVIDIA in a matter tied to chips and issues surrounding its former chief executive, adding another layer of uncertainty for investors.
  • NVIDIA’s latest quarterly report showed revenue and earnings growth well above last year, but the market focused on governance concerns rather than only the operating beat.
  • The company’s outlook called for lower gross margins in the next quarter and assumed no data center compute revenue from China, which may have reinforced worries about profitability and geopolitical exposure.
  • Sources:

    NVIDIA Investor Relations, SEC, AP News

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $NVDA Insider Trading Activity

    NVDA Insider Trades

    $NVDA insiders have traded $NVDA stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.

    Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:

    • MARK A STEVENS has made 0 purchases and 21 sales selling 6,121,740 shares for an estimated $1,353,730,171.
    • TIMOTHY S. TETER (EVP, General Counsel and Sec) has made 0 purchases and 6 sales selling 60,460 shares for an estimated $13,323,047.
    • COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 34,918 shares for an estimated $7,648,632.
    • STEPHEN C NEAL sold 15,500 shares for an estimated $3,343,863
    • JOHN DABIRI sold 625 shares for an estimated $133,750

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive NVDA Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $NVDA Hedge Fund Activity

    We have seen 3,203 institutional investors add shares of $NVDA stock to their portfolio, and 2,625 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $NVDA Congressional Stock Trading

    Members of Congress have traded $NVDA stock 25 times in the past 6 months. Of those trades, 11 have been purchases and 14 have been sales.

    Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $NVDA Analyst Ratings

    Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 24 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Cantor Fitzgerald issued a "Overweight" rating on 11/18/2026
    • Piper Sandler issued a "Overweight" rating on 11/18/2026
    • Morgan Stanley issued a "Overweight" rating on 11/18/2026
    • TD Cowen issued a "Buy" rating on 11/18/2026
    • Wedbush issued a "Outperform" rating on 11/18/2026
    • RBC Capital issued a "Outperform" rating on 11/18/2026
    • Rosenblatt issued a "Buy" rating on 11/18/2026

    To track analyst ratings and price targets for $NVDA, check out Quiver Quantitative's $NVDA forecast page.

    $NVDA Price Targets

    Multiple analysts have issued price targets for $NVDA recently. We have seen 36 analysts offer price targets for $NVDA in the last 6 months, with a median target of $230.0.

    Here are some recent targets:

    • C.J. Muse from Cantor Fitzgerald set a target price of $250.0 on 11/18/2026
    • Matt Bryson from Wedbush set a target price of $293.0 on 11/18/2026
    • Jim Kelleher from Argus Research set a target price of $220.0 on 11/18/2026
    • Timothy Arcuri from UBS set a target price of $220.0 on 11/18/2026
    • Harlan Sur from JP Morgan set a target price of $230.0 on 11/18/2026
    • David O'Connor from Piper Sandler set a target price of $230.0 on 11/18/2026
    • Kevin Cassidy from Rosenblatt set a target price of $300.0 on 11/18/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles